Development and validation of a modified phenoage for biological aging and chronic diseases in a chinese cohort.
Abstract
To address the original PhenoAge's reliance on C-reactive protein (CRP)-a non-routine clinical biomarker-and enhance practical utility in routine healthcare settings, we developed a modified algorithm (PA-CRP) excluding CRP while retaining its core multi-omics integration framework, and further evaluated its associations with chronic diseases and lifestyle factors in a Chinese cohort.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims to have developed a modified algorithm for assessing biological aging that excludes CRP while maintaining a multi-omics approach. This research is relevant as it seeks to improve the assessment of biological aging, which is a fundamental aspect of longevity research and understanding age-related diseases.
Author of this paper? Send a correction.